Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Dnake
300884
5
Shanghai DOBE Cultural & Creative Industry Development
300947
CN Stock MarketDetailed Quotes
300109 Boai NKY Medical
- 15.85
- +0.20+1.28%
Trading May 7 09:38 CST
7.68BMarket Cap24.88P/E (TTM)
15.97High15.79Low16.15KlotVolume15.84Open15.65Pre Close25.61MTurnover0.36%Turnover Ratio21.98P/E (Static)484.70MShares18.9852wk High2.07P/B7.11BFloat Cap9.7652wk Low18.78Limit Up448.34MShs Float59.97Historical High12.52Limit Down1.15%Amplitude1.44Historical Low0.67Dividend TTM15.86Avg Price7.00KlotAsk4.21%Div YieldTTM100Lot Size8.14KlotBid
Boai NKY Medical News
New Open Source: Announcement on the 2024 Profit Distribution Plan
New Open Source: Beijing Yunjia Law Firm\'s Legal Opinion on the Achievements of the New Open Source 2023 Restricted Stock Incentive Plan for the Second Vesting Period
New open source: Announcement on the achievements of the vesting conditions for the second vesting period of the 2023 Restricted Stock Incentive Plan
New open source: Supervisory Board\'s opinion on the list of eligible incentive recipients for the 2023 Restricted Stock Incentive Plan
New open source: Announcement on the release of the pledge of a portion of the shares of the controlling shareholder and actual controller
New open source: Announcement on the release of the pledge of a portion of the shares of the controlling shareholder and actual controller
New open source: Simplified equity change report (Wang Donghu, Yang Haijiang, Zhang Junzheng, Yang Hongbo)
New Open Source: Simplified Equity Change Report (Ren Dalong)
New open source: Announcement on the release of the pledge of a portion of the shares of the controlling shareholder and actual controller
New Open Source: Announcement on partial equity pledges by the controlling shareholder and actual controller
Boai NKY Medical: Announcement regarding the completion of the cancellation of a portion of restricted share buyback under the 2021 Restricted Stock Incentive Plan.
Boai NKY Medical: Announcement to creditors regarding the repurchase and cancellation of restricted stock incentive plan for 2021.
Boai NKY Medical: Announcement on the First Release of Restricted Stock Incentive Plan for 2021 and the Reserved Release of Second Release Restriction Period and the Listing and Circulation of Restricted Stock Shares upon the Release of Restriction Period.
Boai NKY Medical: Supervisory board's verification opinion regarding stock-based incentive plan related matters.
Boai NKY Medical: Announcement on Adjusting Relevant Matters of Restricted Stock Incentive Plan in 2023
Boai NKY Medical: Legal Opinion of Beijing Dacheng Law Firm on the Adjustment, Removal of Restrictive Conditions, Achievement of Restricted Stock and Buyback and Cancellation Matters of Boai Nky Medical Technology Group Co., Ltd.'s 2021 Restricted Stock Incentive Plan.
Boai NKY Medical: Announcement regarding the first release of the third restricted stock incentive plan for 2021 and the achievement of the unlocking conditions for reserving the second release of the unlocking period.
Boai NKY Medical: Independent financial advisory report on the adjustment, lifting of restrictions and cancellation of repurchase of Boai Nky Medical Technology Group Co., Ltd.'s restricted stock incentive plan achievements and conditions by Shenzhen Tashan Enterprise Management Consulting Co., Ltd.
Boai NKY Medical: Announcement regarding the repurchase and cancellation of restricted stocks under the 2021 Restricted Stock Incentive Plan.
Boai NKY Medical: Announcement Regarding Adjustments to the 2021 Restricted Stock Incentive Plan
Market Insights
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting